동공 측정기 시장 : 예측(2026-2031년)

The pupillometer market is anticipated to grow at a 6.63% CAGR, reaching USD 779.397 million in 2031 from USD 530.398 million in 2025.

The pupillometer market is experiencing rapid growth driven by rising neurological disorder prevalence, technological innovation, and expanding clinical applications. Pupillometry-the measurement of pupil dilation to understand various underlying diseases-has become increasingly valuable as imaging modalities including MRI and CT have demonstrated direct correlations between brain activity and pupil dilation. This diagnostic approach aids deeper understanding of cognitive processes and provides insights into both normal eye functionality and illness-affected brain activity. Individuals with autism spectrum disorder, Parkinson's disease, depression, and anxiety display aberrant pupillometry responses to stimuli, expanding the technology's clinical utility across diverse neurological and psychiatric conditions.

Primary Market Drivers

Neurological Disorder Burden

The global burden of non-communicable neurological illnesses is rising, primarily driven by aging populations. Principal causes of neurological illnesses include epilepsy, headache conditions, and stroke. Pupillometers measure eye curvature to identify neurological problems, creating rising demand for these instruments as patient populations expand. The anticipated growth in persons affected by neurological illnesses positions the pupillometer market for sustained development throughout the projected period, as healthcare systems require increasingly sophisticated diagnostic tools for growing patient populations.

Government and Organizational Initiatives

Numerous governmental and commercial organizations are working to increase understanding of neurological illnesses and enhance healthcare access. The International Neuromodulation Society, a non-profit organization devoted to advancing neuromodulation science, disseminates information and encourages neuromodulation through conferences, peer-reviewed publications, educational material, and online platforms. These awareness campaigns and healthcare access advancements drive pupillometer market expansion by creating more informed healthcare providers and patients who understand the value of objective neurological assessment.

Hand-Held Pupillometer Adoption

Hand-held pupillometers are anticipated to develop at the quickest rate during the projected period. Portable pupillometers enable users to quickly and precisely capture pupil images for diagnosing neurological conditions including Alzheimer's disease. The hand-held format's convenience and mobility are driving increased development and popularity. NeurOptics represents a leading manufacturer of handheld pupillometers for critical care and practical research applications. Additionally, companies like Adaptica have developed hybrid hand-held devices such as 2WIN that incorporate pupillometry functionality, demonstrating innovation in form factor and feature integration.

Video Pupillometer Technology

Video pupillometers enable recording of complete pupil dilation processes, facilitating understanding of variations and their underlying causes. NeurOptics, specializing in pupillometry science, employs cutting-edge technology enabling physicians to deliver improved patient care. The company has developed various video pupillometers for critical care and practical research. The NPi-200 video pupillometer for critical care features infrared cameras, CPUs, highly accurate optics, and LED light sources. Video functionality aids documenting how pupil size and response vary over time, providing temporal data unavailable through static measurements.

Technological Advancement

Technological improvements have substantially enhanced pupillometer accuracy, usefulness, and usability. While traditional pupillometers measured pupillary responses using visible light, infrared pupillometry has become the standard in contemporary devices. Infrared light provides greater precision and dependability, particularly under diverse lighting situations, eliminating environmental variables that previously complicated measurements.

Modern pupillometers incorporate high-resolution cameras with cutting-edge imaging capabilities to capture accurate, detailed pupil photographs. Additionally, artificial intelligence algorithms are being developed and implemented to enhance diagnostic capabilities. AI integration enables more sophisticated pattern recognition, potentially identifying subtle pupillary response abnormalities that might escape human observation, expanding diagnostic sensitivity and specificity.

Regional Dynamics

North American Market Leadership

North America holds the majority of pupillometer market share due to rising neurological illness frequency and vision-related issues. Acceptance and installation of pupillometers across diverse U.S. settings is anticipated to fuel market share growth. Major industry companies like NeurOptics, headquartered in the United States, are developing sophisticated pupillometers for improved diagnosis. Companies are investigating pupillometer applications in various critical care domains to broaden product utility for additional medical problems, expanding the addressable market beyond traditional neurological applications.

Asia Pacific Growth Potential

The Asia Pacific region is anticipated to demonstrate major growth potential during the projected period. Expanding pupillometer access through various online marketplaces and providers is expected to support regional market expansion. Major international manufacturers including NeurOptics, Johnson & Johnson Vision, and Konan Medical offer pupillometers through regional subsidiaries. NeurOptics distributes through partners in India, Japan, and South Korea-Hansraj Nayyar Medical India, IMI Co., and Neuroplus. International players like NIDEK have improved regional pupillometer access and availability, supporting market development in this high-growth region.

Strategic Industry Approaches

Pupillometer market participants engage in trade events, exhibits, and conferences to raise knowledge of pupillometry and showcase product ranges. Industry players develop portable devices addressing mobility concerns and improving device usability across varied contexts. Companies have developed cutting-edge software installable on mobile devices to complete pupillometry processes remotely, expanding accessibility and enabling point-of-care applications.

Recent developments include December 2022 incorporation of NeurOptics' Neurological Pupil Index and automated pupillometry into updated European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for post-resuscitation care as objective measurements supporting neurological prognosis in cardiac arrest patients. In May 2022, NeurOptics launched the NPi-300 pupillometer across 15 nations including the United Kingdom, France, Italy, Ireland, Australia, and New Zealand.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Pupillometer Market Segmentation

• By Type
• Video
• Digital
• By Mobility
• Table-top
• Hand-held
• By Application
• Ophthalmology
• Neurology
• Oncology
• Others
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PUPILLOMETER MARKET BY TYPE

• 5.1. Introduction
• 5.2. Video
• 5.3. Digital

6. PUPILLOMETER MARKET BY MOBILITY

• 6.1. Introduction
• 6.2. Table-top
• 6.3. Hand-held

7. PUPILLOMETER MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Ophthalmology
• 7.3. Neurology
• 7.4. Oncology
• 7.5. Others

8. PUPILLOMETER MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. NeurOptics, Inc.
• 10.2. Adaptica
• 10.3. Essilor Instruments USA
• 10.4. Haag-Streit Group
• 10.5. Johnson & Johnson Vision
• 10.6. Visionix
• 10.7. NIDEK CO., LTD.
• 10.8. Reichert Technologies
• 10.9. SCHWIND eye-tech-solutions
• 10.10. US Ophthalmi

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations